Herbas VPB

Print
EN | LT
LT - HER2 HETEROGENEITY AS A BIOMARKER IN CANCER
EN - HER2 HETEROGENEITY AS A BIOMARKER IN CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/574 (2006.01)
G01N 33/574 (2013.01)
G01N 33/57415 (2013.01)
G01N 33/57446 (2013.01)
European patent
(11) Number of the document 3797296
(13) Kind of document T
(96) European patent application number 19727597.7
Date of filing the European patent application 2019-05-20
(97) Date of publication of the European application 2021-03-31
(45) Date of publication and mention of the grant of the patent 2024-09-04
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2019/062972
Date 2019-05-20
PCT application publication
(87) Number WO 2019/224153
Date 2019-11-28
Priority applications
(30) Number Date Country code
201862674566 P 2018-05-21 US
Inventors
(72)
MURILLO, Adrian E. , US
NITTA, Hiro , US
MUNROE, Donald G. , US
LO, Amy A. , US
KUWATA, Takeshi , JP
KAITO, Akio , JP
OCHIAI, Atsushi , JP
Grantee
(73) GENENTECH, INC. , 1 DNA Way, South San Francisco, CA 94080, US
Ventana Medical Systems, Inc. , 1910 E. Innovation Park Drive, Tucson, Arizona 85755, US
National Cancer Center , 5-1-1, Tsukiji Chuo-ku, Tokyo 104-0045, JP
Title
(54) HER2 HETEROGENEITY AS A BIOMARKER IN CANCER
  HER2 HETEROGENEITY AS A BIOMARKER IN CANCER